|
|
|
|
LEADER |
03871nam a22004695i 4500 |
001 |
13110 |
003 |
DE-He213 |
005 |
20130727041124.0 |
007 |
cr nn 008mamaa |
008 |
121116s2013 xxu| s |||| 0|eng d |
020 |
# |
# |
|a 9781461446545
|9 978-1-4614-4654-5
|
024 |
7 |
# |
|a 10.1007/978-1-4614-4654-5
|2 doi
|
050 |
# |
4 |
|a RC261-271
|
072 |
# |
7 |
|a MJCL
|2 bicssc
|
072 |
# |
7 |
|a MED062000
|2 bisacsh
|
082 |
0 |
4 |
|a 614.5999
|2 23
|
100 |
1 |
# |
|a Koehn, Frank E.
|e editor.
|
245 |
1 |
0 |
|a Natural Products and Cancer Drug Discovery
|c edited by Frank E. Koehn.
|h [electronic resource] /
|
264 |
# |
1 |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2013.
|
300 |
# |
# |
|a XII, 244 p. 94 illus., 17 illus. in color.
|b online resource.
|
336 |
# |
# |
|a text
|b txt
|2 rdacontent
|
337 |
# |
# |
|a computer
|b c
|2 rdamedia
|
338 |
# |
# |
|a online resource
|b cr
|2 rdacarrier
|
347 |
# |
# |
|a text file
|b PDF
|2 rda
|
490 |
1 |
# |
|a Cancer Drug Discovery and Development
|
505 |
0 |
# |
|a Preface.-� The Impact of Natural Products upon Cancer Chemotherapy -- Identification and development of vascular disrupting agents: Natural products that interfere with tumor growth -- Discodermolide: Past, Present and Future -- HDAC Inhibitors and Other Histone Modifying Natural Products as Emerging Anticancer Agents -- Natural Product Cytotoxins As Payloads For Antibody Drug Conjugates -- Natural Product Scaffolds in Cancer Therapy -- The Role of Genetic Engineering in Natural Product-based Anticancer Drug Discovery -- Accessing Anti-Cancer Natural Products by Plant Cell Culture -- Natural Products as Tools for Discovering New Cancer Targets -- Index.
|
520 |
# |
# |
|a Natural products- compounds derived from plants, microbes and marine organisms, have been an unsurpassed source of cancer drugs in the modern era of drug discovery.� The historical record is strong, but what is the current impact of natural� products in the discovery and development of cancer drugs, and importantly what are the prospects for natural products to be a valuable source of �future agents?� This volume attempts to address this question through a series of chapters authored by leading researchers in the field which effectively provide an in-depth view of several high impact areas of natural products cancer research. The volume begins with a focused analysis and rationale for the clinical success� of current natural product anti-cancer drugs. The following chapters then describe new natural product based drugs in three rapidly evolving target classes and modalities- agents which target tumor vasculature, inhibitors of histone deacetylase and other histone modifying enzymes, and �antibody drug conjugates.� Subsequent chapters examine the central role of natural product chemical scaffolds in the genesis of new anti-cancer therapeutics- first via the powerful application of chemical synthesis, and then through the �rapidly emerging fields of biosynthetic engineering and plant cell culture. �The volume concludes with an assessment of the critical role that natural products continue to play in the search for new cancer drug targets.� As the reader makes his or her way through the volume it may become clear that there is strong evidence that natural products will continue to exert a profound positive impact on cancer drug discovery.
|
650 |
# |
0 |
|a Medicine.
|
650 |
# |
0 |
|a Oncology.
|
650 |
# |
0 |
|a Toxicology.
|
650 |
1 |
4 |
|a Biomedicine.
|
650 |
2 |
4 |
|a Cancer Research.
|
650 |
2 |
4 |
|a Oncology.
|
650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
710 |
2 |
# |
|a SpringerLink (Online service)
|
773 |
0 |
# |
|t Springer eBooks
|
776 |
0 |
8 |
|i Printed edition:
|z 9781461446538
|
830 |
# |
0 |
|a Cancer Drug Discovery and Development
|
856 |
4 |
0 |
|u https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-1-4614-4654-5
|
912 |
# |
# |
|a ZDB-2-SME
|
950 |
# |
# |
|a Medicine (Springer-11650)
|